Latest revenue
—
as of —
Latest net income
—
as of —
Net margin
—
as of —
Price · 5Y
Market data
Price feed temporarily unavailable for RBOT.
5-year trend
What this company does
ITEM 1. BUSINESS. The following discussion reflects the business of Vicarious Surgical, as currently embodied by Vicarious Surgical. Unless the context otherwise requires, all references in this section to the “Company”, “we”, “us” and “our” generally refer to Vicarious Surgical in the present tense or Vicarious Surgical from and after the Business Combination. Overview We are combining advanced miniaturized robotics, computer science, sensing and 3D visualization to build a new category of intelligent and affordable single-port surgical robots that virtually transport surgeons inside the patient to perform minimally invasive surgery. With our next-generation robotics technology, which is…
AI summary unavailable — showing raw filing excerpt
Generated from RBOT's filing dated 2026-03-09
Key risks
ITEM 1A. RISK FACTORS. Careful consideration should be given to the following risk factors, in addition to the other information set forth in this Annual Report on Form 10-K, including the section of titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and our consolidated financial statements and related notes, and in other documents that we file with the SEC, in evaluating our company and our business. Investing in our securities involves a high degree of risk. If any of the events described in the following risk factors actually occur, our business, financial condition, results of operations and future growth prospects could be materially and…
AI summary unavailable — showing raw filing excerpt
Generated from RBOT's filing dated 2026-03-09
Profitability
Return on equity
-509.9%
276.6%Return on assets
-256.3%
174.5%Leverage
Debt / equity
0.99×
119.9%Long-term debt / equity
0.18×
2097.3%Debt / assets
49.7%
60.2%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | — | — | $-7.3M | +52.4% | — |
Q4 2025 2025-12-31 | — | — | $-10.5M | +24.5% | — |
Q3 2025 2025-09-30 | — | — | $-11.1M | +35.3% | — |
Q2 2025 2025-06-30 | — | — | $-13.2M | +13.1% | — |
Q1 2025 2025-03-31 | — | — | $-15.4M | +9.5% | — |
Q4 2024 2024-12-31 | — | — | $-13.9M | — | — |
Q3 2024 2024-09-30 | — | — | $-17.1M | -8.8% | — |
Q2 2024 2024-06-30 | — | — | $-15.2M | +0.8% | — |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Orthopedic, Prosthetic & Surgical Appliances & Supplies · SIC 3842
Your notes
Keep private notes on RBOT — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$0
Insider selling
$63.1K
Net activity
−$63.1K
Distinct insiders
3
Open-market trades over the last 365 days.
Recent transactions
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns RBOT
Institutional value
$345
Total shares held
3.8K
Distinct holders
5
-31 vs prior
As of
2026-03-31
Prior: 2025-12-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | Hughes Financial Services, LLC | 333 | $240 | +0 (+0.0%) | No change |
| 2 | Daytona Street Capital LLC | 100 | $80 | +0 (+0.0%) | No change |
| 3 | SIGNATUREFD, LLC | 16 | $12 | +0 (+0.0%) | No change |
| 4 | Sound Income Strategies, LLC | 13 | $11 | +0 (+0.0%) | No change |
| 5 | Forum Finance Group S.A. | 3.3K | $2 | — | New |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once RBOT's latest filing finishes processing.